Hyperthermic intraoperative intraperitoneal chemotherapy safety considerations.

by S K White, a D Stephens, P H Sugarbaker
AORN journal ()


Perioperative staff members encounter many occupational exposure hazards in the workplace. Cytotoxic agent exposure is a relatively new hazard that perioperative staff members are experiencing as more surgeons use hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) to treat patients with abdominopelvic cavity malignancies. Routes of exposure include inhalation, ingestion, injection, and skin contact. The National Cancer Institute, the Occupational Safety and Health Administration, and the Joint Commission on Accreditation of Healthcare Organizations provide guidelines for the safe administration and handling of cytotoxic agents. Institutions in which cytotoxic agents are administered should use these guidelines to develop policies, procedures, and educational programs to protect surgical patients and perioperative staff members.

Cite this document (BETA)

Readership Statistics

5 Readers on Mendeley
by Discipline
40% Psychology
20% Environmental Sciences
20% Medicine
by Academic Status
40% Doctoral Student
20% Researcher (at a non-Academic Institution)
20% Assistant Professor

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in